No Result
View All Result
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions
Smart Investment Today
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Smart Investment Today
No Result
View All Result
Home Stock

QUTENZA® Phase III Clinical Trial for Post-Surgical Neuropathic Pain Successfully Enrolls Participants, Thanks to Partnership between Grünenthal and Averitas Pharma

by
November 7, 2024
in Stock
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Aachen, Germany & Morristown, N.J. – Grünenthal, a global leader in pain management and related diseases, announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial aims to evaluate the efficacy, safety, and tolerability of QUTENZA® (capsaicin) 8% topical system in post-surgical neuropathic pain (PSNP). If successful…

Source

Previous Post

Reeves reassures on trade as Trump tariffs threaten UK-US economic ties

Next Post

The Limits to Public Opinion and the Failure of Democracy

Next Post

The Limits to Public Opinion and the Failure of Democracy

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • Trending
    • Comments
    • Latest

    Gold Prices Rise as the Dollar Slowly Dies

    May 25, 2024

    Richard Murphy, The Bank of England, And MMT Confusion

    March 15, 2025

    We Can’t Fix International Organizations like the WTO. Abolish Them.

    March 15, 2025

    Free Markets Promote Peaceful Cooperation and Racial Harmony

    March 15, 2025
    Can Aluminium Alloy Help You Achieve Net-Zero Goals?

    Can Aluminium Alloy Help You Achieve Net-Zero Goals?

    0

    Ana-Maria Coaching Marks Milestone with New Book Release

    0

    The Consequences of California’s New Minimum Wage Law

    0

    Memorial Day

    0
    Can Aluminium Alloy Help You Achieve Net-Zero Goals?

    Can Aluminium Alloy Help You Achieve Net-Zero Goals?

    July 30, 2025

    “Amidst Kabul’s Fall Anniversary, Afghan Diaspora Gathers for Two-Day Event in Feltham After Four Years”

    July 30, 2025
    Why I Signed the Economists’ Amicus Brief Challenging Trump’s Emergency Tariffs

    Why I Signed the Economists’ Amicus Brief Challenging Trump’s Emergency Tariffs

    July 30, 2025

    Beijing Finance Officials and Hong Kong Investors Visit London for Potential Partnership with Dunbai International.

    July 30, 2025

    Recent News

    Can Aluminium Alloy Help You Achieve Net-Zero Goals?

    Can Aluminium Alloy Help You Achieve Net-Zero Goals?

    July 30, 2025

    “Amidst Kabul’s Fall Anniversary, Afghan Diaspora Gathers for Two-Day Event in Feltham After Four Years”

    July 30, 2025
    Why I Signed the Economists’ Amicus Brief Challenging Trump’s Emergency Tariffs

    Why I Signed the Economists’ Amicus Brief Challenging Trump’s Emergency Tariffs

    July 30, 2025

    Beijing Finance Officials and Hong Kong Investors Visit London for Potential Partnership with Dunbai International.

    July 30, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 smartinvestmenttoday.com | All Rights Reserved

    No Result
    View All Result
    • News
    • Economy
    • Editor’s Pick
    • Investing
    • Stock

    Copyright © 2025 smartinvestmenttoday.com | All Rights Reserved